Skip to main content
Premium Trial:

Request an Annual Quote

SignalGene, National Research Council Form Genomics Collaboration

Premium

MONTREAL--SignalGene announced that it has formed a functional genomics collaboration with the National Research Council of Canada’s Institute for Biological Sciences to study neurodegenerative diseases. The collaboration’s objective is to identify novel targets to develop new therapeutic drugs to treat disorders such as Alzheimer’s and Parkinson’s diseases. SignalGene will apply its proprietary technologies to analyze gene expression patterns in human pathology samples and biological models of neuro-degeneration prepared for or developed by NRC researchers.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.